Antifungal pregnancy risk warning


Regulators are warning women of a possible risk of miscarriage following use of an oral antifungal. The US Food and Drug Administration has issued an announcement in late April advising caution when prescribing oral fluconazole (Diflucan) in pregnancy. They say an evaluation of data from a Danish study indicates a possible increased risk of miscarriage

This content is restricted. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Pressure rising for overworked pharmacists
Next Forum: I’m here to make a difference in the health of my patients